NDIDIAMAKA MBAKPUO: Open Payments
NPI 1336638089 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 19 payments from 8 companies in 2025. Trend: 2023 $243 · 2024 $784 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 4 | $95 |
| ABBVIE INC. | 4 | $79 |
| Supernus Pharmaceuticals, Inc. | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $22 |
| TMS NeuroHealth Centers Inc. | 1 | $16 |
Products named: VRAYLAR, Qelbree, REXULTI, Auvelity, ABILIFY ASIMTUFII, INGREZZA, INVEGA SUSTENNA, APTIMA.
Industry payments across MD — which companies pay providers there.
